Mylan has issued a nationwide voluntary recall of injectable amiodarone, an antiarrhythmic for in-hospital use, that may have been mislabeled as tranexamic acid injection, according to the US Food and ...

(RTTNews) - Generic and specialty pharma company Mylan N.V. said its U.S.-based business Mylan Institutional LLC recalled four lots of Amiodarone HCl Injection, USP and Tranexamic Acid Injection, USP ...

Credit: FDA. The FDA has received reports of tranexamic acid injection being erroneously administered intrathecally in the perioperative setting instead of the intended intrathecal anesthetic (eg, ...

Inadvertent administration may result in serious adverse events. Mylan announced the voluntary recall to the hospital/clinic level of 4 lots of Amiodarone HCl Injection, USP 450mg/9mL and Tranexamic ...

Mylan N.V. (NASDAQ: MYL) today announced that its U.S.-based Mylan Institutional LLC business is conducting a voluntary nationwide recall to the hospital/clinic level of four lots of Amiodarone HCl ...

The FDA is requiring updated labeling for tranexamic acid injection to emphasize the risk of serious harm, including death, if administered incorrectly via spinal injection. Tranexamic acid injection ...

SCHAUMBURG, Ill.--(BUSINESS WIRE)--Avenacy, a specialty pharmaceutical company focused on supplying critical injectable medications, today announced it has launched Tranexamic Acid Injection, USP in ...

The Institute for Safe Medication Practices added tranexamic acid injection solutions to its high-alert medications list, which registers drugs linked with a high ...

SCHAUMBURG, Ill.--(BUSINESS WIRE)--APP Pharmaceuticals, LLC, a Fresenius Kabi Company, today announced it has acquired three products from Nexus Pharmaceuticals, Inc. Under terms of the agreement APP ...

Tranexamic acid is highly efficacious for the treatment of melasma, with optimal outcomes seen through oral administration plus routine topical agents. The efficacy of tranexamic acid alone against ...

Tranexamic acid can reduce bleeding and bruising caused by upper eyelid blepharoplasty while facilitating surgery, researchers say. Administered in a local anesthesia injection, the drug caused no ...

After a priority review, the FDA has announced its approval of tranexamic acid, the first nonhormonal product cleared to treat heavy menstrual bleeding, a condition reported each year by about 3 ...